Deutsche Bank downgraded Tecan (TCHBF) to Hold from Buy with a price target of CHF 225, down from CHF 298. With 7%-8% of sales exposed to National Institutes of Health funding, Tecan appears particularly vulnerable to spending cuts, the analyst tells investors in a research note.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCHBF: